semaglutide and cagrilintide Cagrilintide–Semaglutide in Adults with Overweight or Obesity Type 2 Diabetes Semaglutide, a glucagon-like peptide-1 (GLP-1)

Easy measuring: At ~1.11 mg/mL, 1 unit 11.1 mcg on a U-100 syringe (1 unit = 0.01 mL)

Enomoto, A

Reported Side Effects (rare) Mild fatigue or dizziness Temporary headache Injection site irritation Nausea (usually mild and transient) Safety Notes Should only be sourced from pharmaceutical-grade compounding pharmacies BPC-157 is prohibited by WADA for competitive athletes Personalized BPC-157 Dosage Approach Unlike generalized online dosing charts, personalized peptide protocols are typically designed under professional supervision to match an individuals health profile and recovery goals

Personalized Plans Your care plan is built to reflect your unique health needs and lifestyle

Patients typically target 250 mcg to 500 mcg injected subcutaneously to support tendon recovery and gut inflammation